In utero antiseizure medication exposure and the risk of psychiatric disorders
A collaborative of Scandinavian researchers led from Aarhus University in Denmark have published a large prospective, population-based register study including over 4.5 million study subjects which investigated the risk of psychiatric disorders following in utero ASM exposure. The study findings indicate that n utero valproate, topiramate and levetiracetam exposure may be associated with increased risks of neurodevelopmental impairment, ADHD and/or anxiety. More information can be found here.
Photo by Robina Weermeijer on Unsplash